Cleared Traditional

K233943 - Affera Mapping System (AFR-00003) (FDA 510(k) Clearance)

Also includes:
Location Reference Patch Kit (AFR-00007) System Cart (AFR-00013)
Mar 2024
Decision
85d
Days
Class 2
Risk

K233943 is an FDA 510(k) clearance for the Affera Mapping System (AFR-00003). This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).

Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on March 8, 2024, 85 days after receiving the submission on December 14, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.

Submission Details

510(k) Number K233943 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 14, 2023
Decision Date March 08, 2024
Days to Decision 85 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQK — Computer, Diagnostic, Programmable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1425

Similar Devices — DQK Computer, Diagnostic, Programmable

All 44
HemoSphere Nano Monitor (HSNANO1)
K253186 · Edwards Lifesciences, LLC · Feb 2026
CARTO™ 3 EP Navigation System V8.4
K252972 · Biosense Webster, Inc. · Feb 2026
Holter ECG and ABP system (HolterABP)
K251591 · Edan Instruments, Inc. · Feb 2026
CARTO™ 3 EP Navigation System V9.0 with PIU Plus
K254085 · Biosense Webster, Inc. · Jan 2026
LumiGuide Equipment R2.1
K252645 · Philips Medical Systems Nederland B.V. · Oct 2025
EnSite™ X EP System
K252013 · Abbott Medical · Sep 2025